HIF1A and cardiovascular disorder: (2) Venn analysis of DELs with fold change ≥4 (p < 0.05) in proliferative HASMCs and DELs with fold change ≥2 (p < 0.05) in human advanced atherosclerotic plaques (GSE97210) (34) revealed three lncRNAs (HIF1A-AS2, RP11-841O20.2, and AC018647.3) were shared, in which HIF1A-AS2 is significantly augmented in peripheral blood monocyte cells of coronary artery disease patients (35), indicating that HIF1A-AS2 might be a promising therapeutic and diagnostic target for cardiovascular diseases.